1,5-anhydroglucitol has been researched along with Complications of Diabetes Mellitus in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Coresh, J; Grams, ME; Gross, AL; Rebholz, CM; Sang, Y; Selvin, E | 1 |
| Kiniwa, N; Koga, M; Matsui, H; Matsumura, Y; Okumiya, T; Tokuhiro, S | 1 |
| Sato, A | 1 |
| Ishii, S; Katabami, T; Kato, H; Kawata, T; Koganei, R; Kondo, A; Matsui, T; Murakami, K; Ohta, A; Sada, Y; Suwa, T; Tanaka, Y | 1 |
| Bando, Y; Kanehara, H; Kasayama, S; Koga, M; Mukai, M; Murai, J; Saito, H; Tanaka, N; Toya, D | 1 |
| Foo, JP; Mantzoros, CS | 1 |
| Emoto, M; Inoue, T; Morii, H; Nishizawa, Y; Tabata, T | 1 |
1 review(s) available for 1,5-anhydroglucitol and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
[Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
Topics: Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycemic Index; Humans; Hyperglycemia; Reference Standards; Serum Albumin | 2014 |
6 other study(ies) available for 1,5-anhydroglucitol and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease.
Topics: Biomarkers; Blood Glucose; Cohort Studies; Deoxyglucose; Diabetes Complications; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hyperglycemia; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Regression Analysis; Risk Factors; Surveys and Questionnaires | 2017 |
Hemolysis causes a decrease in HbA1c level but not in glycated albumin or 1,5-anhydroglucitol level.
Topics: Adult; Aged; Deoxyglucose; Diabetes Complications; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Hemolysis; Humans; Middle Aged; Serum Albumin | 2019 |
Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM).
Topics: Aged; Area Under Curve; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Monitoring, Ambulatory; Regression Analysis; Serum Albumin | 2010 |
1,5-Anhydroglucitol levels are low irrespective of plasma glucose levels in patients with chronic liver disease.
Topics: Blood Glucose; Case-Control Studies; Chronic Disease; Deoxyglucose; Diabetes Complications; Female; Humans; Liver Diseases; Male; Middle Aged; Multivariate Analysis; Regression Analysis | 2011 |
The quest for the perfect biomarker of long-term glycemia: new studies, new trials and tribulations.
Topics: Animals; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Predictive Value of Tests; Serum Albumin | 2011 |
Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
Topics: Adult; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis | 1992 |